01 Ulrich Reineke 2010

Ulrich Reineke

Position
CEO
Location
Berlin, DE
Bio

Ulrich Reineke is co-founder and managing director of 3B Pharmaceuticals in Berlin, Germany. His focus is to develop peptides for innovative applications in human health, including pharmaceutical product candidates, molecular imaging agents, synthetic affinity purification ligands for downstream processing, and in vitro diagnostics. Before starting 3B Pharmaceuticals he worked for Jerini AG and joined the company as one of the first employees in 1997. He held several positions, including project leader for contract research projects and strategic alliances with pharmaceutical and biotechnology companies, head of a production unit for peptide array and library synthesis, Director of the Assay Development and Screening Department and later Head of the Lead Discovery Biology department. Key areas of experience are target selection as well as hit identification and lead optimization projects up to preclinical development. He participated in the discovery of several peptidomimetic and small molecule drug candidates, some of them already in clinical development. For over 10 years Ulrich Reineke has supported and influenced the development of Jerini from a small biotechnology company to an integrated pharmaceutical company. Ulrich Reineke graduated from the Free University Berlin and received his PhD from the Humboldt-University Berlin for research into the identification of biologically active peptides and the characterization of protein interactions. He received the Charité Research Award in 1998 and the Tiburtius Award of the City of Berlin in 2000 for his achievements. He has authored more than 60 scientific publications and is named as co-inventor for 15 patent applic

Interests
, , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , ,